Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2005;45:288-293
Published online before print December 20, 2004, doi: 10.1161/01.HYP.0000152700.58940.b2
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
45/2/288    most recent
01.HYP.0000152700.58940.b2v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aiello, E. A.
Right arrow Articles by Pérez, N. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aiello, E. A.
Right arrow Articles by Pérez, N. G.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*SODIUM
Related Collections
Right arrow Calcium cycling/excitation-contraction coupling
Right arrow Ion channels/membrane transport

(Hypertension. 2005;45:288.)
© 2005 American Heart Association, Inc.


Scientific Contributions

Endothelin-1 Stimulates the Na+/Ca2+ Exchanger Reverse Mode Through Intracellular Na+ (Na+i)–Dependent and Na+i-Independent Pathways

Ernesto Alejandro Aiello; María Celeste Villa-Abrille; Raúl Ariel Dulce; Horacio Eugenio Cingolani; Néstor Gustavo Pérez

From the Centro de Investigaciones Cardiovasculares, Facultad de Ciencias Médicas, Universidad Nacional de La Plata, Argentina.

Correspondence to Dr Ernesto A. Aiello, Centro de Investigaciones Cardiovasculares, Facultad de Ciencias Médicas, UNLP, 60 y 120 (1900) La Plata, Argentina. E-mail aaiello{at}atlas.med.unlp.edu.ar


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMaterials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
This study aimed to explore the signaling pathways involved in the positive inotropic effect (PIE) of low doses of endothelin-1 (ET-1). Cat papillary muscles were used for force and intracellular Na+ concentration (Na+i) measurements, and isolated cat ventricular myocytes for patch-clamp experiments. ET-1 (5 nmol/L) induced a PIE and an associated increase in Na+i that were abolished by Na+/H+ exchanger (NHE) inhibition with HOE642. Reverse-mode Na+/Ca2+ exchanger (NCX) blockade with KB-R7943 reversed the ET-1–induced PIE. These results suggest that the ET-1–induced PIE is totally attributable to the NHE-mediated Na+i increase. However, an additional direct stimulating effect of ET-1 on NCX after the necessary increase in Na+i could occur. Thus, the ET-1–induced increase in Na+i and contractility was compared with that induced by partial inhibition of the Na+/K+ ATPase by lowering extracellular K+ (K+o). For a given Na+i, ET-1 induced a greater PIE than low K+o. In the presence of HOE642 and after increasing contractility and Na+i by low K+o, ET-1 induced an additional PIE that was reversed by KB-R7943 or the protein kinase C (PKC) inhibitor chelerythrine. ET-1 increased the NCX current and negatively shifted the NCX reversal potential (ENCX). HOE642 attenuated the increase in NCX outward current and abolished the ENCX shift. These results indicate that whereas the NHE-mediated ET-1–induced increase in Na+i seems to be mandatory to drive NCX in reverse and enhance contractility, Na+i-independent and PKC-dependent NCX stimulation appears to additionally contribute to the PIE. However, it is important to stress that the latter can only occur after the primary participation of the former.


Key Words: contraction • ion channels • endothelin


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMaterials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Endothelin-1 (ET-1) is a powerful inotropic agent that induces this effect acting through different intracellular signaling pathways.1–4 However, at doses that increase contractility by {approx}20%, the positive inotropic effect (PIE) is entirely attributable to activation of the reverse mode of the Na+/Ca2+ exchanger (NCX).5 This increase in contractility is similar in magnitude to that detected during the slow force response of myocardial stretch.6–8 A sustained increase in intracellular Ca2+ through the NCX reverse mode induced by an increase in intracellular Na+ (Na+i) produced by the activation of the Na+/H+ exchanger (NHE) may represent the signaling link between this transporter and cardiac hypertrophy.9–11 In fact, we demonstrated recently that this mechanism is responsible for the increase in contractility induced by ET-1.5 We proposed that ET-1 activates the NHE, which increases Na+i and shifts the NCX reversal potential (ENCX) to a more negative voltage. These changes give more time for NCX to operate in reverse mode during the action potential and promote Ca2+ influx to the cell, determining the increase in force.5

It is well known that activation of protein kinase C (PKC) is a downstream pathway of ET-1 receptor binding.4 Consistently, it has been shown that PKC phosphorylates the NCX protein after ET-1 stimulation.12 Moreover, a direct PKC-dependent increase in the NCX current (INCX) induced by ET-1 in guinea pig myocytes was reported previously.13 Thus, the possibility exists that a direct effect of ET-1 on NCX could also contribute to the PIE of this peptide after NCX is driven to the reverse mode by the mandatory increase in Na+i produced by activation of the NHE. In other words, the increase in Na+i could be a necessary but not exclusive condition to mediate the ET-1–induced Ca2+ influx through the NCX reverse mode. The investigation of this hypothesis constitutes the main purpose of the present study.

The overall results obtained herein allow us to suggest that the cardiac NCX reverse mode is modulated by ET-1 through 2 different pathways: (1) an Na+i-dependent one, consistent with a negative shift of ENCX after a rise in Na+i attributable to the NHE activation; and (2) an Na+i-independent and PKC-dependent NCX stimulation. Both pathways appear to contribute to the ET-1–induced PIE. However, the latter seems to contribute to this effect only after primary participation of the former, which appears to be a mandatory step.


*    Materials and Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Materials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
The investigation conforms to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996).

Cat papillary muscles were used for registering developed force, intracellular pH (pHi), and Na+i measurements, and isolated cat ventricular myocytes were used for patch-clamp experiments. Na+i and pHi were determined by epifluorescence. A detailed description of these techniques is presented in an expanded Materials and Methods section, available online at http://www.hypertensionaha.org.

Experimental Protocols
To analyze the above-mentioned hypothesis, 3 different experimental approaches were assayed in the present work. (1) We compared the increase in Na+i and force promoted by ET-1 to those induced by partial inhibition of the Na+/K+ATPase; (2) We tested the ability of ET-1 to induce a PIE after driving the NCX in reverse mode by increasing Na+i through the partial inhibition of the Na+/K+ ATPase in the presence of NHE blockade; and (3) We evaluated the effects of ET-1 on outward INCX in the presence and absence of NHE inhibition.

Pharmacological Interventions
HOE642 (1 µmol/L) was used to inhibit the NHE, KB-R7943 (5 µmol/L), to inhibit the NCX reverse mode, and chelerythrine (1 µmol/L), to block PKC activation.

Statistics
Data are expressed as mean±SEM. To detect significant differences, paired or unpaired t test or repeated-measures 1-way ANOVA followed by Student Newman–Keuls as post hoc test were used as appropriate. A P<0.05 was considered to indicate significant differences.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
*Results
down arrowDiscussion
down arrowReferences
 
Figure 1 shows the effects of ET-1 (5 nmol/L) on contractile behavior (Figure 1A and 1B), on Na+i (Figure 1C), and on pHi (Figure 1D) of isolated cat papillary muscles. Control values for force and Na+i across groups are shown in the table. The results indicate that the PIE of ET-1: (1) is abolished by both, NHE-1 blockade with HOE642 (1 µmol/L) and by the inhibitor of the NCX reverse mode, KB-R7943 (5 µmol/L); and (2) is accompanied by an increase in Na+i without changes in pHi. The lack of changes in pHi after NHE activation when bicarbonate is present in the medium has been suggested previously.5,6,14 Note that a further increase in Na+i was detected after application of KB-R7943, suggesting that this compound blocked the exchange of Na+i for extracellular Ca2+.



View larger version (13K):
[in this window]
[in a new window]
 
Figure 1. Effect of ET-1 on contractility and Na+i in cat papillary muscles. A, Typical force record of an isometrically contracting cat papillary muscle showing the PIE promoted by 5 nmol/L ET-1 and its suppression after inhibition of the NCX reverse mode with 5 µmol/L KB-R7943. B, Averaged results of 5 experiments like those shown in A (filled symbols) and cancellation of the ET-1–induced PIE after inhibition of NHE with 1 µmol/L HOE642 (open symbols; n=4). C, Increase in force observed with ET-1 was accompanied by a rise in Na+i that continued after NCX inhibition (filled symbols). Preincubation with HOE642 prevented the increase in developed force (DF) and Na+i, supporting the notion that NHE activation, and thus Na+i increase, is a mandatory step to increase force (open symbols). D, Addition of ET-1 did not produce any change in papillary muscle pHi (n=4).


View this table:
[in this window]
[in a new window]
 
Control Values of Developed Force (DF) and Na+i of the Different Experimental Groups



View larger version (24K):
[in this window]
[in a new window]
 
Figure 4. ET-1 is able to further increase force after an increase in contractility induced by low K+o in the presence of NHE inhibition. A, representative continuous recording of force of a papillary muscle pretreated with 1 µmol/L HOE642 and exposed successively to low K+o, 5 nmol/L ET-1, and 5 µmol/L KB-R7943. In the continuous presence of HOE642 in the extracellular medium, ET-1 applied after the increase in contractility produced by low K+o was able to induce an additional PIE that was completely reversed by KB-R7943. B, Averaged changes in developed force (DF) at steady state of 3 experiments like those shown in A.



View larger version (16K):
[in this window]
[in a new window]
 
Figure 5. PKC mediates the additional increase in force promoted by ET-1 after the increase in contractility induced by low K+o in the presence of NHE inhibition. A, Average time course changes of developed force (DF) in 3 muscles subjected to a similar sequence of interventions to that shown in Figure 4A except for the addition of the PKC inhibitor chelerythrine (Che; 1 µmol/L) instead of KB-R7943. Once again, ET-1 applied after the increase in contractility produced by low K+o further increased force, but this time, only this additional effect was reversed by chelerythrine, suggesting a direct PKC-mediated phosphorylation effect of ET-1 on NCX. B, Interestingly, neither the additional PIE promoted by ET-1 nor its reversion by chelerythrine affected Na+i, giving strong support to the notion that ET-1 exerts Na+-dependent (Figure 1) and -independent effects on force.

Although these experiments are suggesting that the PIE of this ET-1 dose is entirely attributable to stimulation of the NCX reverse mode, the possibility exists that the compound used for blocking this NCX operation mode would be acting on other mechanisms. However, as shown in Figure 2, this was not the case. We were unable to show any effect of KB-R7943 (5 µmol/L) on contractility under our control conditions (Figure 2A). These results also indicate that the NCX reverse mode does not contribute to basal contractility. KB-R7943 even failed to affect contractility after increasing it by enhancing extracellular Ca2+ concentration in a magnitude enough to increase developed force by {approx}20% (Figure 2B), which is the effect produced by the dose of ET-1 used in the present work.



View larger version (15K):
[in this window]
[in a new window]
 
Figure 2. Effect of KB-R7943 on basal contractility and after increasing force by increasing extracellular Ca2+ concentration. Inhibition of NCX reverse mode by 5 µmol/L KB-R7943 did not affect basal contractility (A) or an increase in force of {approx}20% promoted by augmentation of extracellular Ca2+ to 1.9 mmol/L (B), supporting the notion that at this concentration, KB-R7943 does not elicit nonspecific effects. DF indicates developed force.

To test the possibility that in addition to the Na+i-dependent mechanism, there is also a direct stimulatory effect of ET-1 on NCX, pilot experiments in which an increase in Na+i promoted by partial inhibition of the Na+/K+ ATPase with ouabain were performed. Although no systematic studies were done to establish the relationship between the increase in Na+i and developed force in our preparations, no consistent relationship between both parameters was found after 1, 2, or 5 µmol/L ouabain (data not shown). These results might be explained by nonspecific effects of this compound15,16 or failure to select the right dose. Then we decided to increase Na+i by partial inhibition of the Na+/K+ ATPase by lowering extracellular K+ (K+o). Figure 3 shows that when Na+i was increased by this maneuver, the increase in developed force showed a linear relationship with Na+i. This increase in developed force was blunted by KB-R7943 (5 µmol/L; Figure 3, inset), indicating that it was attributable to activation of the NCX reverse mode. However, when the Na+i levels were augmented by ET-1–induced activation of NHE, the increase in force lies above this relationship. Therefore, for a given Na+i, the increase in developed force was greater when the increase in Na+i was attributable to ET-1 than when it was induced by low K+o. This finding suggests that ET-1 is driving the NCX in reverse mode by increasing Na+i by NHE activation, but it also has additional effects favoring the Ca2+ influx through NCX.



View larger version (15K):
[in this window]
[in a new window]
 
Figure 3. Effect of increasing Na+i by partial inhibition of the Na+/K+ ATPase on cardiac contractility. When Na+i was increased by partial inhibition of Na+/K+ ATPase after lowering K+o to 2 different concentrations (1.8 mmol/L, solid squares; 0.9 mmol/L, solid triangles), the increase in developed force (DF) showed a linear relationship with Na+i (y=6.54+3.69x). This increase in force may conceivably be assigned to activation of the NCX reverse mode because it was reverted by KB-R7943 (5 µmol/L; inset). However, when Na+i levels were augmented by ET-1–induced NHE activation, the results lie above the relationship. In other words, for a similar increase in Na+i, the increase in force was significantly greater in the presence of ET-1, suggesting that this peptide is driving NCX in reverse mode not only through an NHE-mediated increase in Na+i but also by an additional effect that favors more Ca2+ influx.

If ET-1 is directly stimulating NCX through a PKC pathway,12,13 and this mechanism is inducing additional effects to NHE activation, we should detect a further increase in developed force at higher-than-normal Na+i and under NHE blockade. Figure 4 shows that this was the case. After the low K+o-induced PIE and despite the NHE inhibition, an additional increase in force was now evident when ET-1 was added to the extracellular solution (Figure 4A). KB-R7943 reversed both PIEs, that of low K+o and that of ET-1, indicating that they were attributable to activation of the NCX reverse mode. On average, ET-1 induced an increase of developed force of 10.8±0.4% with respect to the steady-state value obtained with low K+o (Figure 4B). To confirm that this ET-1–induced PIE is Na+i independent, we performed additional experiments in which we simultaneously recorded force and Na+i (Figure 5). A similar pharmacological protocol of Figure 4 was followed, but in this case, instead of KB-R7943, the PKC inhibitor chelerythrine (1 µmol/L) was added after the ET-1–induced PIE reached a steady-state level. Figure 5 clearly shows that under these experimental conditions, ET-1 produces a PIE in the absence of changes in Na+i and that this increase in contractility is completely reversed by PKC inhibition. These overall results indicate that ET-1 is able to induce a PKC-dependent PIE in the presence of NHE inhibition only after the increase in Na+i produced by low K+o, which drives the NCX to the reverse mode. These experiments also indicate that part of the PIE of ET-1 is Na+i independent and thus unrelated to the change in ENCX produced by the increase in Na+i.

If there are changes induced by ET-1 occurring through the NCX in reverse independent of the alterations in the ENCX, we should detect changes in the INCX insensitive to NHE blockade. Thus, we next recorded whole-cell currents evoked by depolarizing steps between –80 and +80 mV in 10-mV increments from a holding potential of –40 mV. Figure 6A shows the average current-voltage (I-V) relationship for INCX before and after addition of ET-1 to the bath solution. A statistically significant ET-1–induced enhancement in outward INCX was observed at potentials higher than –10 mV with 1 nmol/L ET-1 and at potentials higher than –40 mV with 10 nmol/L ET-1. A significant increase in inward INCX was also observed at –70 and –80 mV with 10 nmol/L ET-1. A linear fitting of the individual data points of the I-V for each cell was performed to detect the 0 current level of INCX, representing ENCX, in the absence and presence of ET-1. ET-1 dose-dependently produced a significant ENCX negative shift (Figure 6B).



View larger version (21K):
[in this window]
[in a new window]
 
Figure 6. Effects of ET-1 on INCX in the absence and presence of NHE inhibition. A, ET-1 effects on average I-V relations for INCX in the absence of HOE642 (n=8). Whole-cell currents were evoked by depolarizing pulses from –80 to +80 mV in 10-mV increments from a holding potential of –40 mV. Currents were recorded before (control) and after successive addition of 1 nmol/L ET-1, 10 nmol/L ET-1, and 10 mmol/L NiCl2 in the continuous presence of ET-1. INCX was obtained as Ni2+-sensitive currents, after subtraction of the currents in the presence of Ni2+ to those in the absence and presence of ET-1. B, Negative shift of the ENCX (n=8) obtained from INCX after successive addition of 1 and 10 nmol/L ET-1 and expressed as the difference from control ({Delta}ENCX). C, ET-1 effects on average I-V relations for INCX in the presence of 1 µmol/L HOE642 (n=9). Currents were recorded in the continuous presence of HOE642 and before (control) and after successive addition of 1 nmol/L ET-1, 10 nmol/L ET-1, and 10 mmol/L NiCl2 in the presence of ET-1. D, {Delta}ENCX (n=9) obtained from Ni2+-sensitive currents after successive addition of 1 and 10 nmol/L ET-1 in the presence of HOE642. Asterisk indicates statistically different from control.

To evaluate whether the ET-1–induced ENCX negative shift was attributable to an increase in Na+i secondary to the activation of the NHE, experiments in the presence of HOE642 were performed. Figure 6C shows the effect of HOE642 on the average I-V for INCX before and after the addition of ET-1 to the bath solution. A statistically significant ET-1–induced enhancement in outward INCX was observed at potentials >+40 mV with 1 nmol/L ET-1 and at potentials higher than –30 mV with 10 nmol/L ET-1. A significant increase in inward INCX was also observed at –70 and –80 mV with 10 nmol/L ET-1. HOE642 did not affect basal INCX (Figure 6A and 6C). No shift in ENCX was observed in the presence of HOE642 (Figure 6D), indicating that the ET-1–induced negative shift observed in the absence of this inhibitor was attributable to the increase in Na+i generated by activation of NHE. No significant changes in basal ENCX were observed with the NHE inhibitor (–39.2±5.4 and –49.5±5.1 in the absence [n=8] and presence of HOE642 [n=9], respectively).

To further analyze the net effect of ET-1 on NCX, we compared the relative increase in INCX induced by ET-1 in the absence and presence of the NHE inhibitor. ET-1 induced a greater augmentation of INCX in the absence of HOE642 than in the presence of this NHE inhibitor (at 0 mV with 10 nmol/L ET-1; 3.5±0.8- and 1.9±0.5-fold increase in the absence [n=8] and presence of HOE642 [n=9], respectively; P<0.05). The most likely interpretation of these results is that when the ENCX negative shift was prevented by HOE642, stimulation of the NCX reverse mode was limited to the direct effect of ET-1 on NCX. On the other hand, when Na+i was allowed to rise in the absence of NHE inhibition, both effects of ET-1 on the NCX were evident: the increase in the driving force for the reverse mode induced by the ENCX negative shift and direct stimulation of NCX.


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
*Discussion
down arrowReferences
 
We can conclude that a low dose of ET-1, equipotent to the slow force response to myocardial stretch6–8 and to doses of angiotensin II that promote the release of ET-1,5 increases myocardial force by increasing Na+i through the activation of NHE, which in turn stimulates the NCX reverse mode. In the present work, we attempted to answer the following question: Is this increase in Na+i the only mechanism responsible for these mechanical changes? A simplistic approach would be that if prevention of the increase in Na+i by blocking NHE prevented development of the mechanical counterpart, then the increase in Na+i is the determinant of the contractile effect. However, the possibility that the increase in Na+i could be a necessary but not an exclusive mechanism to induce the Ca2+ influx through the NCX in reverse should be considered. In this regard, we are presenting evidence that although blockade of the NCX reverse mode abolished the mechanical counterpart manifested after a rise in Na+i, induced either by ET-1 or by Na+/K+ ATPase inhibition, for a given increase in Na+i, the increase in developed force was greater when activation of the NCX reverse mode was induced by ET-1 than when the Na+/K+ ATPase was inhibited. Moreover, we also demonstrated that in the presence of NHE inhibition, ET-1 applied after the increase in Na+i produced by low K+o was able to induce an additional PIE that was completely reversed by inhibition of the NCX reverse mode.

These results strongly suggest that factors affecting the NCX reverse mode other than the increase in Na+i and the consequent ENCX negative shift are participating when the increase in force is mediated by ET-1. In this regard, our electrophysiological experiments are indicating that ET-1 is also producing a direct stimulation of NCX. A phosphorylation of NCX by a PKC-dependent mechanism has been proposed12,13 and might represent the subcellular pathway leading to direct stimulation of this transporter. Consistently, we showed in the present work that PKC mediates the Na+i-independent PIE detected in the experiments in which ET-1 was applied after low K+o in the presence of NHE inhibition. The possibility that ET-1–induced activation of different PKC isoforms may represent a common pathway for both, Na+i-dependent and -independent effects on NCX, constitutes an interesting hypothesis that deserves further research.

Taking into account the values of the ET-1–induced ENCX negative shift detected in the present study and considering that Ca2+o, Ca2+i, and Na+o were 2 mmol/L, 200 nmol/L, and 140 mmol/L, respectively, the change in Na+i can be calculated with the equation: ENCX=3ENa–2ECa, where ENa and ECa are the equilibrium potentials for Na+ and Ca2+, respectively. Thus, the values of the estimated increase in Na+i were 1.57±0.51 and 5.22±1.32 mmol/L for 1 and 10 nmol/L ET-1 (n=8), respectively. These values are of the same order of magnitude to those measured in the bulk of the cytosol by epifluorescence in papillary muscles after addition of 5 nmol/L ET-1 (Figure 1C). However, it is important to note that the increase in Na+i in the isolated myocytes might reflect changes of this ion in a space in which intracellular dialysis with the solution of the patch pipette cannot maintain the Na+ concentration at a constant level.

Although it is difficult to imagine how the increase in Na+i can only enhance the NCX reverse mode without slowing the forward mode, we would like to call attention to the fact that the selective inhibitor of the NCX reverse mode blunted the contractile response. However, we cannot completely rule out a contribution of a reduced forward mode of the NCX to the increase in Ca2+i.

Together, the results presented herein indicate that the cardiac NCX reverse mode is modulated by ET-1 through 2 different pathways: (1) a negative shift of ENCX after a rise in Na+i because of NHE activation, and (2) an increase in the turnover rate of the NCX units induced by a PKC-dependent pathway. Both pathways appear to contribute to the ET-1–induced PIE. However, the increased turnover rate seems to contribute to this effect only after the change in ENCX produced by NHE activation, which appears to be a necessary step. The fact that basal levels of Na+i are increased in some myocardial diseases such as hypertrophy17,18 or heart failure18,19 permit the speculation that it would not be mandatory that the aforementioned mechanisms should take place in series. Thus, the relative contribution of these 2 pathways to the ET-1–induced increase in contractility in pathological states is an interesting forthcoming perspective that deserves future attention.

Study Limitations
The main limitations of our study rely on the comparison of the contractile response with an increase in Na+i levels by 2 different interventions, namely ET-1 and low K+o. Although we demonstrated that both interventions increase contractility by NCX in reverse, and that for a given increase in Na+i, ET-1 induced a greater increase in contractility than inhibition of the Na+/K+ ATPase, the following possibilities should be analyzed: (1) Despite an equal Na+i in the bulk of the cytosol, the increase of Na+i induced by ET-1 would be higher in a fuzzy space close to NCX. However, a colocalization of NCX and NHE,20,21 and also of NCX and the Na+/K+ ATPase,22 have been reported; (2) ET-1 could induce a greater prolongation of the action potential duration (APD) than low K+o, then the influx of Ca2+ through the NCX reverse mode would be greater than that induced by Na+/K+ ATPase inhibition. Although the increase in APD by ET-1 has been reported,23,24 low K+o can also induce a prolongation of APD,25 and the differences between both interventions are difficult to evaluate; (3) The way selected by us to increase Na+i (low K+o), by hyperpolarizing the cell, may promote Ca2+ efflux through the forward mode of NCX, thus reducing PIE. However, no negative inotropic effect was observed after complete block with KB-R7943 of the low K+o-induced PIE (Figure 3, inset); and (4) The increase in Na+i produced by either ET-1 or inhibition of the Na+/K+ ATPase may affect regulation of ion channels (ie, Na+-activated K+ channels26) and alter membrane potential. However, in our experiments, these potential effects of increased Na+i unlikely influence the contractile behavior because the PIE induced by ET-1 or Na+/K+ ATPase inhibition was completely cancelled by selective inhibition of the NCX reverse mode.


*    Acknowledgments
 
This work was supported by grant (PEI) 6020 from the Consejo Nacional de Investigaciones Científicas (CONICET), Argentina (E.A.A.) and grants PICT 05-08512 from Agencia Nacional de Promoción Científica y Tecnológica, Argentina, and PIP 02255 from CONICET (H.E.C.).

Received September 17, 2004; first decision October 4, 2004; accepted November 29, 2004.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
up arrowDiscussion
*References
 

  1. Takanashi M, Endoh M. Characterization of positive inotropic effect of endothelin on mammalian ventricular myocardium. Am J Physiol. 1991; 261: H611–H619.[Medline] [Order article via Infotrieve]
  2. Lamers JM, De Jonge HW, Panagia V, Van Heugten HA. Receptor-mediated signaling pathways acting through hydrolysis of membrane phospholipids in cardiomyocytes. Cardioscience. 1993; 4: 121–131.[Medline] [Order article via Infotrieve]
  3. Endoh M, Fujita S, Yang HT, Talukder MA, Maruya J, Norota I. Endothelin: receptor subtypes, signal transduction, regulation of Ca2+ transients and contractility in rabbit ventricular myocardium. Life Sci. 1998; 62: 1485–1489.[CrossRef][Medline] [Order article via Infotrieve]
  4. Sugden PH. An overview of endothelin signaling in the cardiac myocyte. J Mol Cell Cardiol. 2003; 35: 871–886.[CrossRef][Medline] [Order article via Infotrieve]
  5. Pérez NG, Villa-Abrille MC, Aiello EA, Dulce RA, Cingolani HE, Camilión de Hurtado MC. A low dose of angiotensin II increases inotropism through activation of reverse Na+/Ca2+ exchange by endothelin release. Cardiovasc Res. 2003; 60: 589–597.[CrossRef][Medline] [Order article via Infotrieve]
  6. Pérez NG, Camilión de Hurtado MC, Cingolani HE. Reverse mode of the Na+/Ca2+ exchange following myocardial stretch. Underlying mechanism of the slow force response. Circ Res. 2001; 88: 376–382.[Abstract/Free Full Text]
  7. von Lewinski D, Stumme B, Maier LS, Luers C, Bers DM, Pieske B. Stretch-dependent slow force response in isolated rabbit myocardium is Na+ dependent. Cardiovasc Res. 2003; 57: 1052–1061.[Abstract/Free Full Text]
  8. von Lewinski D, Stumme B, Fialka F, Luers C, Pieske B. Functional relevance of the stretch-dependent slow force response in failing human myocardium. Circ Res. 2004; 94: 1392–1398.[Abstract/Free Full Text]
  9. Baartscheer A, Schumacher CA, van Borren MMGJ, Belterman CNW, Coronel R, Fiolet JWT. Increased Na+/H+-exchange activity is the cause of increased [Na+]i and underlies disturbed calcium handling in the rabbit pressure and volume overload heart failure model. Cardiovasc Res. 2003; 57: 1015–1024.[Abstract/Free Full Text]
  10. Cingolani HE, Camilión de Hurtado MC. Na+-H+ exchanger inhibition: a new antihypertrophic tool. Circ Res. 2002; 90: 751–753.[Free Full Text]
  11. Ennis IL, Escudero EM, Console GM, Camihort G, Dumm CG, Seidler RW, Camilion de Hurtado MC, Cingolani HE. Regression of isoproterenol-induced cardiac hypertrophy by Na+/H+ exchanger inhibition. Hypertension. 2003; 41: 1324–1329.[Abstract/Free Full Text]
  12. Iwamoto T, Pan Y, Wakabayashi S, Imagawa T, Yamanaka HI, Shigekawa M. Phosphorylation dependent regulation of cardiac Na+/Ca2+ exchanger via protein kinase C. J Biol Chem. 1996; 271: 13609–13615.[Abstract/Free Full Text]
  13. Zhang YH, James AF, Hancox JC. Regulation by endothelin-1 of Na+-Ca2+ exchange current (INaCa) from guinea-pig isolated ventricular myocytes. Cell Calcium. 2001; 30: 351–360.[CrossRef][Medline] [Order article via Infotrieve]
  14. Ganz MB, Boyarsky G, Sterzel RB, Boron WF. Arginine vasopressin enhances pHi regulation in the presence of HCO3 by stimulating three acid-base transport systems. Nature. 1989; 337: 648–651.[CrossRef][Medline] [Order article via Infotrieve]
  15. Santana LF, Gomez AM, Lederer WJ. Ca2+ flux through promiscuous cardiac Na+ channels: slip-mode conductance. Science. 1998; 279: 1027–1033.[Abstract/Free Full Text]
  16. Nishio M, Ruch SW, Wasserstrom JA. Positive inotropic effects of ouabain in isolated cat ventricular myocytes in sodium-free conditions. Am J Physiol Heart Circ Physiol. 2002; 283: H2045–H2053.[Abstract/Free Full Text]
  17. Gray RP, McIntyre H, Sheridan DS, Fry CH. Intracellular sodium and contractile function in hypertrophied human and guinea pig myocardium. Pflügers Arch. 2001; 442: 117–123.[CrossRef][Medline] [Order article via Infotrieve]
  18. Verdonck F, Volders PG, Vos MA, Sipido KR. Intracellular Na+ and altered Na+ transport mechanisms in cardiac hypertrophy and failure. J Mol Cell Cardiol. 2003; 35: 5–25.[CrossRef][Medline] [Order article via Infotrieve]
  19. Baartscheer A, Schumacher CA, Belterman CN, Coronel R, Fiolet JW. [Na+]i and the driving force of the Na+/Ca2+-exchanger in heart failure. Cardiovasc Res. 2003; 57: 986–995.[Abstract/Free Full Text]
  20. Petrecca K, Atanasiu R, Grinstein S, Orlowski J, Shrier A. Subcellular localization of the Na+/H+ exchanger NHE1 in rat myocardium. Am J Physiol. 1999; 276: H709–H717.[Medline] [Order article via Infotrieve]
  21. Brette F, Komukai K, Orchard CH. Validation of formamide as a detubulation agent in isolated rat cardiac cells. Am J Physiol. 2002; 283: H1720–H1728.
  22. Despa S, Brette F, Orchard CH, Bers DM. Na/Ca exchange and Na/K-ATPase function are equally concentrated in transverse tubules of rat ventricular myocytes. Biophys J. 2003; 85: 3388–3396.[Abstract/Free Full Text]
  23. Yorikane R, Koike H, Miyake S. Electrophysiological effects of endothelin-1 on canine myocardial cells. J Cardiovasc Pharmacol. 1991; 17: S159–S162.
  24. Woo SH, Lee CO. Effects of endothelin-1 on Ca2+ signaling in guinea-pig ventricular myocytes: role of protein kinase C. J Mol Cell Cardiol. 1999; 31: 631–643.[CrossRef][Medline] [Order article via Infotrieve]
  25. White E, Terrar DA. Action potential duration and the inotropic response to reduced extracellular potassium in guinea-pig ventricular myocytes. Exp Physiol. 1991; 76: 705–716.[Abstract]
  26. Veldkamp MW, Vereecke J, Carmeliet E. Effects of intracellular sodium and hydrogen ion on the sodium-activated potassium channel in isolated patches from guinea-pig ventricular myocytes. Cardiovasc Res. 1994; 28: 1036–1041.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
J. Physiol.Home page
C. I. Caldiz, C. D. Garciarena, R. A. Dulce, L. P. Novaretto, A. M. Yeves, I. L. Ennis, H. E. Cingolani, G. Chiappe de Cingolani, and N. G. Perez
Mitochondrial reactive oxygen species activate the slow force response to stretch in feline myocardium
J. Physiol., November 1, 2007; 584(3): 895 - 905.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. E. Cingolani and I. L. Ennis
Sodium-Hydrogen Exchanger, Cardiac Overload, and Myocardial Hypertrophy
Circulation, March 6, 2007; 115(9): 1090 - 1100.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
P. Eder, D. Probst, C. Rosker, M. Poteser, H. Wolinski, S.D. Kohlwein, C. Romanin, and K. Groschner
Phospholipase C-dependent control of cardiac calcium homeostasis involves a TRPC3-NCX1 signaling complex
Cardiovasc Res, January 1, 2007; 73(1): 111 - 119.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
45/2/288    most recent
01.HYP.0000152700.58940.b2v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aiello, E. A.
Right arrow Articles by Pérez, N. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aiello, E. A.
Right arrow Articles by Pérez, N. G.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*SODIUM
Related Collections
Right arrow Calcium cycling/excitation-contraction coupling
Right arrow Ion channels/membrane transport